Roche Holding AG (RHHBF)
333.66
-13.64 (-3.93%)
At close: Apr 21, 2025, 3:34 PM
-3.93% (1D)
| Bid | 326.66 |
| Market Cap | 254.88B |
| Revenue (ttm) | 59.69B |
| Net Income (ttm) | 10.62B |
| EPS (ttm) | 12.57 |
| PE Ratio (ttm) | 26.54 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 350.61 |
| Volume | 3 |
| Avg. Volume (20D) | 162 |
| Open | 348.00 |
| Previous Close | 347.30 |
| Day's Range | 333.66 - 348.00 |
| 52-Week Range | 251.26 - 380.00 |
| Beta | 0.22 |
About RHHBF
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neu...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Aug 3, 2012
Employees 103,249
Stock Exchange PNK
Ticker Symbol RHHBF
Website https://www.roche.com